CHM chimeric therapeutics limited

Diamond Reserch Report, page-9

  1. 340 Posts.
    lightbulb Created with Sketch. 27
    I am still very optimistic about CHM, mainly because of Paul Hopper and LC.

    Their experience will be critical in driving investor interest, especially as they will likely have to raise more funds in 6 - 9 months.

    Maybe I am missing something here, but there does seem to be a cross over between CF33 and CHM; why would there be a merger/takeover if the results look good? Or is there more value in CHM going it alone?

    The timeline to approval is definitely shorter with CHM compared to IMU so hopefully, that will help in any future fund raise.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
-0.001(25.0%)
Mkt cap ! $6.045M
Open High Low Value Volume
0.4¢ 0.4¢ 0.3¢ $22.28K 6.311M

Buyers (Bids)

No. Vol. Price($)
78 84735861 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 86304338 23
View Market Depth
Last trade - 14.27pm 25/07/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.